In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.

BMC Cancer · 2009 · PMC2702392 · PMID 19531212

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

a strong trendP = 0.057so close (0.05 < p ≤ 0.1)

However, a strong trend towards an association between tumor cell expression of aromatase and ER was found, ( P = 0.057).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.